Report cover image

Global Veterinary Pharmacovigilance Market Size Study, By Solution (Software, Services), By Type (In-house, Contract Outsourcing), By Product (Biologics, Anti-Infective, Others), By Animal Type (Dogs, Cats, Other Animal Types), And Regional Forecasts 2024

Publisher Factview Research
Published Oct 03, 2025
Length 285 Pages
SKU # FAVR20464246

Description

The Global Veterinary Pharmacovigilance Market was valued at USD 913.89 million in 2024 and is projected to expand at a CAGR of 14.3% from 2024 to 2034. This rapid expansion is driven by increasing veterinary drug approvals, growing awareness about veterinary pharmacovigilance reporting, stricter regulatory compliance requirements, and public and private initiatives to ensure drug safety for animals.

The rising pet ownership, increasing demand for advanced veterinary medicines, and growing investments in pharmacovigilance technologies are further propelling market growth. The emphasis on adverse event monitoring, signal detection, and post-market surveillance of veterinary drugs has become paramount, leading to the adoption of pharmacovigilance software solutions and services. Furthermore, regulatory authorities worldwide are imposing stricter guidelines for veterinary drug approvals and pharmacovigilance inspections, ensuring the safety and efficacy of veterinary pharmaceuticals.

The integration of artificial intelligence (AI), data analytics, and machine learning (ML) in veterinary pharmacovigilance is playing a pivotal role in enhancing the accuracy and efficiency of adverse event monitoring. AI-powered pharmacovigilance software enables real-time detection and reporting of adverse drug reactions (ADRs) and medication errors, helping veterinary pharmaceutical companies comply with evolving regulations. For instance, in 2024, the World Health Organization (WHO) expanded its International Drug Monitoring Programme, reflecting a global commitment to strengthening pharmacovigilance systems. Similarly, the European Union (EU) has intensified its focus on continuous signal management to ensure the safety of veterinary medicinal products.

From a regional perspective, North America dominated the veterinary pharmacovigilance market in 2024, holding a 40.0% revenue share, primarily due to well-established veterinary healthcare infrastructure, stringent regulatory guidelines, and the presence of leading pharmacovigilance service providers. The Asia-Pacific region is expected to grow at the fastest CAGR of 15.4% , fueled by rising pet ownership, increasing government regulations on veterinary drug safety, and expanding veterinary healthcare investments in countries like China, India, and Japan.

Major Market Players Included in This Report:
  • ArisGlobal
  • Accenture
  • Ennov
  • Sarjen Systems Pvt. Ltd.
  • Pharsafer Associates Limited
  • Knoell
  • Biologit
  • Indivirtus
  • Azierta Contract Science Support Consulting
  • Oy Medfiles Ltd.
The Detailed Segments and Sub-Segment of the Market Are Explained Below:

By Solution:
  • Software
  • Services
By Type:
  • In-house
  • Contract Outsourcing
By Product:
  • Biologics
  • Anti-Infective
  • Other Products
By Animal Type:
  • Dogs
  • Cats
  • Other Animal Types
By Region:

North America
  • U.S.
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Rest of Europe
Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Thailand
  • Rest of Asia Pacific
Latin America
  • Brazil
  • Argentina
  • Rest of Latin America
Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of Middle East & Africa
Years Considered for the Study:
  • Historical Year – 2022
  • Base Year – 2024
  • Forecast Period – 2024 to 2034
Key Takeaways:
  • Market Estimates & Forecast for 10 years (2022-2034)
  • Annualized Revenue and Regional-Level Analysis for each market segment
  • Geographical Breakdown with country-level market evaluations
  • Competitive Landscape Analysis with information on major market players
  • Insights into Key Business Strategies, Growth Drivers, and Challenges
  • Supply & Demand Side Analysis of the market

Table of Contents

285 Pages
Chapter 1. Global Veterinary Pharmacovigilance Market Executive Summary
1.1. Global Veterinary Pharmacovigilance Market Size & Forecast (2024-2034)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Solution
1.3.2. By Type
1.3.3. By Product
1.3.4. By Animal Type
1.4. Key Trends
1.5. Recession Impact
1.6. Industry Metrics
1.7. Investment Analysis
1.8 .Investment Rationale
1.9. Analyst Recommendation & Conclusion
Chapter 2. Global Veterinary Pharmacovigilance Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Veterinary Pharmacovigilance Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Veterinary Drug Approvals & Regulatory Compliance
3.1.2. Rising Pet Ownership & Livestock Industry Expansion
3.1.3. Growing Demand for Pharmacovigilance Software & Services
3.2. Market Challenges
3.2.1. High Implementation Costs of Pharmacovigilance Solutions
3.2.2. Complex Regulatory Frameworks Across Regions
3.3. Market Opportunities
3.3.1. Integration of AI & Machine Learning in Veterinary Pharmacovigilance
3.3.2. Expansion of Pharmacovigilance Services for Companion Animals
Chapter 4. Global Veterinary Pharmacovigilance Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Veterinary Pharmacovigilance Market Size & Forecasts by Solution (2024-2034)
5.1. Segment Dashboard
5.2. Global Veterinary Pharmacovigilance Market: Solution Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Software
5.2.2. Services
Chapter 6. Global Veterinary Pharmacovigilance Market Size & Forecasts by Type (2024-2034)
6.1. Segment Dashboard
6.2. Global Veterinary Pharmacovigilance Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. In-house
6.2.2. Contract Outsourcing
Chapter 7. Global Veterinary Pharmacovigilance Market Size & Forecasts by Product (2024-2034)
7.1. Segment Dashboard
7.2. Global Veterinary Pharmacovigilance Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Biologics
7.2.2. Anti-Infective
7.2.3. Other Products
Chapter 8. Global Veterinary Pharmacovigilance Market Size & Forecasts by Animal Type (2024-2034)
8.1. Segment Dashboard
8.2. Global Veterinary Pharmacovigilance Market: Animal Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Dogs
8.2.2. Cats
8.2.3. Other Animal Types
Chapter 9. Global Veterinary Pharmacovigilance Market Size & Forecasts by Region (2024-2034)
9.1. North America Veterinary Pharmacovigilance Market
9.1.1. U.S. Veterinary Pharmacovigilance Market
9.1.2. Canada Veterinary Pharmacovigilance Market
9.1.3. Mexico Veterinary Pharmacovigilance Market
9.2. Europe Veterinary Pharmacovigilance Market
9.3. Asia-Pacific Veterinary Pharmacovigilance Market
9.4. Latin America Veterinary Pharmacovigilance Market
9.5. Middle East & Africa Veterinary Pharmacovigilance Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. ArisGlobal
10.1.2. Accenture
10.1.3. Ennov
10.2. Top Market Strategies
10.3. Company Profiles
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.